Cava Group
CAVA
$88.18
+4.71%
CAVA Group, Inc. operates a fast-casual restaurant chain specializing in Mediterranean-inspired cuisine, including customizable bowls, pitas, and salads, and also produces and sells its branded dips, spreads, and dressings through grocery stores. The company has established itself as a high-growth disruptor in the restaurant industry, successfully scaling its brand nationally and capturing significant market share from established players. The current investor narrative is intensely focused on the company's ability to sustain its rapid unit growth and same-store sales momentum while navigating the transition to consistent profitability, a debate that was sharpened by its recent quarterly earnings report which showed a significant year-over-year revenue increase but also a sequential decline in net income.…
CAVA
Cava Group
$88.18
Investment Opinion: Should I buy CAVA Today?
Rating: Hold. The core thesis is that CAVA is a high-quality growth story currently trading at an excessive valuation that fails to adequately discount the clear and recent deterioration in profitability, creating an unfavorable risk/reward profile.
Supporting this Hold rating are several key data points: 1) The extreme forward PE of 118.5x is unsustainable without perfect execution; 2) Revenue growth, while robust at 20.93% YoY, is demonstrably decelerating sequentially; 3) Profitability metrics are moving in the wrong direction, with net income and gross margin compressing sharply in the most recent quarter; 4) While analyst sentiment is mixed, the stock's price already reflects significant optimism, trading just 16% below its all-time high despite these operational headwinds. The positive free cash flow ($26.14M TTM) and healthy balance sheet prevent a Sell rating.
The rating would upgrade to a Buy if the company demonstrates a clear reversal of the margin compression in the next quarterly report, with gross margin recovering above 18% and providing a credible path for net income growth to re-accelerate. It would downgrade to a Sell if revenue growth decelerates below 15% YoY or if net income turns negative, confirming the profitability issues are structural. Based on the current data, the stock is overvalued relative to its near-term fundamentals and peer group, though fairly valued for a long-term investor only if the company can swiftly address its margin challenges.
Sign up to view all
CAVA 12-Month Price Forecast
The assessment is neutral with medium confidence. The powerful technical recovery and robust revenue base are offset by severe and recent profitability warnings and an extreme valuation that prices in perfection. The base case (50% probability) of range-bound trading between $70-$90 is most likely, as the company works through its margin issues amidst a slowing growth rate. The stance would upgrade to bullish only upon clear evidence of margin stabilization and re-acceleration of bottom-line growth. It would turn bearish if the next quarterly report shows further gross margin deterioration or a material slowdown in revenue growth below 15% YoY.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cava Group's 12-month outlook, with a consensus price target around $114.63 and implied upside of +30.0% versus the current price.
Average Target
$114.63
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$71 - $115
Analyst target range
The stock is covered by 8 analysts, and recent institutional ratings show a mix of bullish and neutral stances, with firms like Keybanc (Overweight), Telsey Advisory Group (Outperform), and TD Cowen (Buy) maintaining positive ratings, while Morgan Stanley (Equal-Weight) and Citigroup (Neutral) are more cautious, and Argus Research recently downgraded from Buy to Hold. The consensus, based on earnings estimates, leans bullish but with high expectations embedded, as the average estimated EPS for the forward period is $1.67, implying significant growth from the most recent quarterly EPS of $0.0424. The target price range is implied by revenue estimates, with a low of $2.59 billion and a high of $2.90 billion against an average of $2.82 billion; the wide spread between the low and high estimates signals substantial uncertainty and debate among analysts regarding the company's near-term growth trajectory and margin recovery, which is typical for a high-growth, recently public company like CAVA.
Bulls vs Bears: CAVA Investment Factors
The bull case for CAVA is powered by undeniable top-line growth, strong technical momentum, and a healthy financial foundation for expansion. However, the bear case presents compelling and immediate concerns centered on a severe and sequential collapse in profitability, paired with an extreme valuation that demands flawless execution. Currently, the bearish evidence holds stronger weight because the profitability compression is a concrete, recent data point that directly challenges the core investment thesis of a scalable high-growth disruptor. The single most important tension in the investment debate is whether the Q4 margin collapse is a temporary, explainable blip or the beginning of a structural problem that will prevent CAVA from translating its rapid revenue growth into sustainable profits. The resolution of this margin trajectory will be the primary determinant of the stock's direction.
Bullish
- Explosive Technical Momentum: CAVA has surged 36.67% over the past six months and 19.87% over the last three months, dramatically outperforming the S&P 500 by 32.6 and 22.0 percentage points, respectively. This powerful relative strength indicates strong stock-specific catalysts and investor conviction in the growth story.
- Robust Revenue Growth Trajectory: The company delivered 20.93% year-over-year revenue growth in Q4 2025, building on a history of strong expansion. Analyst consensus projects average forward revenue of $2.82 billion, implying continued top-line momentum as the brand scales nationally.
- Healthy Balance Sheet & Cash Flow: CAVA maintains a strong liquidity position with a current ratio of 1.74 and a manageable debt-to-equity ratio of 0.60. The company generates positive free cash flow ($26.14 million TTM), providing internal capital to fund its aggressive unit growth without excessive leverage.
- Analyst Consensus Leans Bullish: The analyst community, with firms like Keybanc (Overweight) and TD Cowen (Buy), maintains a generally positive outlook. The average forward revenue estimate of $2.82 billion signals institutional confidence in the company's ability to execute its growth plan.
Bearish
- Severe Profitability Compression: Q4 2025 net income collapsed to $4.92 million from $14.75 million in Q3, while gross margin contracted sharply to 14.89% from 20.62% in Q2. This sequential deterioration raises serious questions about the scalability of the business model and cost management.
- Extreme Valuation Premium: CAVA trades at a trailing PE of 109.2x and a forward PE of 118.5x, which is astronomically high compared to typical restaurant sector multiples (20-30x PE). This premium leaves the stock vulnerable to severe multiple compression if growth decelerates or margins fail to recover.
- Revenue Growth is Decelerating: While still strong at 20.93% YoY, Q4 revenue growth represents a sequential slowdown from 29.2% in Q3 and 33.2% in Q1. This deceleration trend, if it continues, could undermine the high-growth narrative that justifies its valuation.
- Extreme Market Volatility (Beta 2.04): With a beta of 2.042, CAVA is over twice as volatile as the broader market. This characteristic, combined with its premium valuation, makes it highly susceptible to sharp drawdowns during market selloffs or sector rotations away from growth stocks.
CAVA Technical Analysis
The stock is in a powerful recovery trend, having surged 36.67% over the past six months, decisively reversing a prior downtrend that saw the price fall 4.31% over the past year. Currently trading at $84.94, the stock sits at approximately 72% of its 52-week range ($43.41 to $101.50), indicating it has recovered significantly from its lows but remains well off its peak, suggesting room for further upside if momentum continues but also highlighting the prior volatility. Recent momentum is exceptionally strong, with the stock up 19.87% over the last three months and 5.52% over the past month, significantly outperforming the S&P 500 (SPY), which was down 2.1% and up only 0.46% over the same periods, respectively, as evidenced by relative strength readings of +21.97 and +5.06. This divergence signals robust stock-specific catalysts and investor enthusiasm, likely tied to strong fundamental execution. Key technical levels are clear, with major support at the 52-week low of $43.41 and immediate resistance at the 52-week high of $101.50; a breakout above resistance would confirm a new bullish phase, while a failure could lead to consolidation. The stock's beta of 2.042 indicates it is over twice as volatile as the broader market, which is critical for risk management as it implies amplified moves in both directions, consistent with its high-growth, high-multiple profile.
Beta
2.04
2.04x market volatility
Max Drawdown
-56.3%
Largest decline past year
52-Week Range
$43-$102
Price range past year
Annual Return
-1.0%
Cumulative gain past year
| Period | CAVA Return | S&P 500 |
|---|---|---|
| 1m | +7.5% | +4.9% |
| 3m | +25.0% | +0.6% |
| 6m | +39.2% | +5.1% |
| 1y | -1.0% | +28.8% |
| ytd | +45.6% | +1.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CAVA Fundamental Analysis
Revenue growth remains robust but shows signs of sequential deceleration; the most recent Q4 2025 revenue was $274.99 million, representing a strong 20.93% year-over-year increase, yet this marks a slowdown from the 29.2% YoY growth in Q3 2025 ($292.24 million) and the 33.2% YoY growth in Q1 2025 ($331.83 million). The company is profitable on a net income basis, with Q4 2025 net income of $4.92 million, but profitability has compressed significantly from the $14.75 million and $18.37 million reported in Q3 and Q2 2025, respectively. Gross margin in Q4 was 14.89%, a sharp contraction from the 20.62% and 18.73% reported in Q2 and Q3, indicating potential cost pressures or promotional activity that is impacting the bottom line trajectory. The balance sheet is healthy with a strong liquidity position, evidenced by a current ratio of 1.74 and a manageable debt-to-equity ratio of 0.60. The company generates positive free cash flow, with TTM free cash flow of $26.14 million, providing internal funding for growth, and its return on equity of 8.18% suggests it is creating shareholder value, albeit at a level that is still maturing as the business scales.
Quarterly Revenue
$274985000.0B
2025-12
Revenue YoY Growth
+0.20%
YoY Comparison
Gross Margin
+0.14%
Latest Quarter
Free Cash Flow
$26141000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CAVA Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is an elevated 109.2x, while the forward PE is 118.5x based on estimated EPS of $1.67; the forward multiple being higher than the trailing multiple suggests analysts expect near-term earnings to dip before resuming growth, reflecting the profitability compression seen in recent quarters. Compared to industry averages, CAVA trades at a significant premium; its trailing PE of 109.2x and Price-to-Sales (PS) ratio of 5.90x are well above typical restaurant sector multiples, which often feature PEs in the 20-30x range and PS ratios around 1-2x. This premium is currently justified by investors betting on its superior growth profile and disruptive potential, but it leaves little room for execution missteps. Historically, the stock's own valuation has been volatile; its current trailing PE of 109.2x is below the extreme highs seen in late 2024 (over 350x) but remains elevated compared to its pre-profitability phases, indicating the market is still pricing in high long-term growth expectations, though with more moderation than during peak optimism.
PE
109.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -8x~615x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
49.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are acute and center on profitability. The sequential net income decline from $18.37M in Q2 to $4.92M in Q4, coupled with the gross margin contraction from 20.62% to 14.89% over the same period, signals significant cost pressure or promotional activity that threatens the path to scalable earnings. While the balance sheet is strong (D/E 0.60), the company's valuation (109x trailing PE) is entirely dependent on sustained hyper-growth; any deceleration below the current ~21% YoY rate could trigger a severe derating. The wide dispersion in analyst revenue estimates ($2.59B low to $2.90B high) underscores the operational uncertainty.
Market & Competitive Risks are elevated due to CAVA's extreme valuation premium. Trading at a trailing PE of 109x and PS of 5.90x versus sector norms (20-30x PE, 1-2x PS) leaves the stock exceptionally vulnerable to valuation compression in a rising rate environment or a rotation out of growth stocks. Its beta of 2.042 confirms it will experience amplified downdrafts in any market pullback. As a disruptor, it also faces the perpetual risk of increased competition from both established fast-casual chains and new entrants into the Mediterranean segment, which could force sustained heavy investment in marketing and promotions, further pressuring margins.
Worst-Case Scenario involves a 'growth stall' combined with sustained margin pressure. If Q4's profitability weakness proves structural and revenue growth decelerates further towards the analyst low estimate, the growth narrative would unravel. This could trigger a wave of analyst downgrades, multiple compression towards sector-average PE ratios, and a rush for the exits by momentum investors. The realistic downside could see the stock re-test its 52-week low of $43.41, representing a potential loss of approximately -49% from the current price of $84.94. The historical max drawdown of -56.28% provides a precedent for such severe volatility.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: The sharp, sequential collapse in net income and gross margin (Q4 gross margin 14.89% vs. 20.62% in Q2) threatens the scalability thesis. 2) Valuation Risk: The extreme PE multiples (109x trailing) leave the stock vulnerable to violent compression if growth stumbles. 3) Operational Risk: Revenue growth is decelerating (from 33.2% to 20.9% YoY over 2025), raising execution questions. 4) Market Risk: With a beta of 2.042, CAVA will fall more than twice as hard as the market in a downturn, a major concern for a richly valued stock.
The 12-month forecast is highly bifurcated, with three primary scenarios. The Base Case (50% probability) sees the stock trading between $70 and $90 as the company works through margin issues in a volatile range. The Bull Case (25% probability), requiring a swift margin recovery, targets $95 to $115. The Bear Case (25% probability), triggered by sustained profitability woes, sees a drop to $43-$60, potentially re-testing the 52-week low. The base case is most likely, implying limited near-term upside from the current ~$85 price until fundamental clarity emerges on margins.
CAVA is significantly overvalued based on traditional fundamental metrics. Its trailing PE of 109.2x and forward PE of 118.5x are stratospheric compared to the restaurant sector average, which typically trades in the 20-30x PE range. Its Price-to-Sales ratio of 5.90x is also a major premium to sector norms of 1-2x. This valuation implies the market expects years of flawless, high-margin growth. Given the recent deceleration in revenue growth and collapse in profitability, the current price does not adequately discount these emerging risks, making the stock appear overvalued on a near-term basis.
CAVA is a high-risk, high-potential-reward stock that is not a good buy for most investors at its current valuation. For aggressive growth investors with a long-term horizon who can stomach extreme volatility (beta 2.04), it represents a speculative bet on a leading brand. However, the recent severe profitability compression (Q4 net income down 67% sequentially) and extreme forward PE of 118.5x create an unfavorable risk/reward profile. It could be a good buy only on a significant pullback or after the company demonstrates a clear and sustained recovery in its gross margins, which currently sit at a concerning 14.89%.
CAVA is strictly a long-term investment for investors with a 3-5 year horizon and high risk tolerance. Its extreme volatility (beta 2.04), lack of dividend, and current valuation dependent on future earnings years away make it a poor candidate for short-term trading or conservative portfolios. The investment thesis is based on the company achieving national scale and mature profitability, a process that will take multiple years and be fraught with quarterly volatility. A short-term trader would be exposed to unpredictable swings driven by earnings reports and sentiment shifts in the growth stock universe.